EUVIMEDEUVIMED entdecken
Crossref

Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis

Yan Zhou, Shiqi Huang, Yizhen Guo, Maoxin Ran, Wenying Shan, Wen-Hua Chen iD, Kin Yip Tam iD

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Yan Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Macau, Taipa, Macau. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Science and Technology Development Fund, Macau SAR, Universidade de Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Upon prolonged use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non‐small‐cell lung cancer (NSCLC), acquired drug resistance inevitably occurs. This study investigates the combined use of EGFR‐TKIs (gefitinib or osimertinib) with epigallocatechin gallate (EGCG) to overcome acquired drug resistance in NSCLC models. The in vitro antiproliferative effects of EGFR‐TKIs and EGCG combination in EGFR‐mutant parental and resistant cell lines were evaluated. The in vivo efficacy of the combination was assessed in xenograft mouse models derived from EGFR‐TKI‐resistant NSCLC cells. We found that the combined use of EGFR‐TKIs and EGCG significantly reversed the Warburg effect by suppressing glycolysis while boosting mitochondrial respiration, which was accompanied by increased cellular ROS and decreased lactate secretion. The combination effectively activated the AMPK pathway while inhibited both ERK/MAPK and AKT/mTOR pathways, leading to cell cycle arrest and apoptosis, particularly in drug‐resistant NSCLC cells. The in vivo results obtained from mouse tumor xenograft model confirmed that EGCG effectively overcame osimertinib resistance. This study revealed that EGCG suppressed cancer bypass survival signaling and altered cancer metabolic profiles, which is a promising anticancer adjuvant of EGFR‐TKIs to overcome acquired drug resistance in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansAnimalsMiceProto-Oncogene Proteins c-aktAMP-Activated Protein KinasesCell ProliferationProtein Kinase InhibitorsDrug Resistance, NeoplasmErbB ReceptorsGlucoseCell Line, TumorMutationAcrylamidesAniline CompoundsIndolesPyrimidinesCatechin

Stichwörter der Autor:innen

EGCGEGFR-TKIsNSCLCacquired drug resistancecombination therapysynergetic effect

Substanzen

Proto-Oncogene Proteins c-aktAMP-Activated Protein KinasesProtein Kinase InhibitorsErbB ReceptorsGlucoseosimertinibAcrylamidesAniline CompoundsIndolesPyrimidines

Autor:innen und Institutionen

  • Faculty of Health Sciences, University of Macau, Taipa, Macau.
  • School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.

ORCID-Profile: Wen-Hua Chen, Kin Yip Tam

Förderung

  • Science and Technology Development Fund, Macau SAR
  • Universidade de Macau

Zitieren

APA

Zhou, Y., Huang, S., Guo, Y., Ran, M., Shan, W., Chen, W. H., & Tam, K. Y. (2023). Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis. Phytotherapy Research. https://doi.org/10.1002/ptr.7990

Vancouver

Zhou Y, Huang S, Guo Y, Ran M, Shan W, Chen WH, et al. Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis. Phytotherapy Research. 2023. doi:10.1002/ptr.7990

BibTeX
@article{Zhou2023,
  author = {Zhou, Yan and Huang, Shiqi and Guo, Yizhen and Ran, Maoxin and Shan, Wenying and Chen, Wen-Hua and Tam, Kin Yip},
  title = {Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7990}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche